# A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

> **NCT06772532** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **COMBINATION_PRODUCT:** BI 456906 - Formulation A
- **DRUG:** BI 456906 - Formulation B
- **DRUG:** BI 456906 - Formulation C

## Key facts

- **NCT ID:** NCT06772532
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-10
- **Primary completion:** 2025-05-29
- **Final completion:** 2025-06-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772532, "A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06772532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*